Patient info

Mebeverine Hydrochloride 135 mg Film-coated Tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
With or without prescription
Medicine strength:
135 mg
Contains active substance:
ATC code:

Patient leaflet - Mebeverine Hydrochloride 135 mg film-coated tablets

1. What Mebeverine tablets are and what they are used for

Mebeverine tablets contain the active substance mebeverine hydrochloride. This belongs to a group of medicines called antispasmodics. This medicine is used to treat the symptoms of irritable bowel syndrome (IBS). This is a very common condition which causes spasm and pain in the gut or intestine. The intestine is a long muscular tube which food passes down so it can be digested. If the intestine goes into spasm and squeezes too tightly, you get pain. The way this medicine works is by relieving the spasm and pain.

The main symptoms of irritable bowel syndrome (IBS) include: • stomach pain and spasm

  • feeling bloated and having wind
  • having diarrhoea (with or without constipation)
  • small, hard, pellet-like or ribbon-like stools (faeces)

These symptoms may vary from person to person.

You must talk to a doctor if you do not feel better or if you feel worse after 14 days.

Your diet and lifestyle can also help treat IBS

How you restrict your diet depends on the way IBS affects you. If you find that certain things bring on the symptoms, then it makes sense not to eat them. A high fibre diet may help, but ask your pharmacist for more information.

Some people find that learning to relax can help to lessen their symptoms of IBS. You may find it helpful to set aside a few moments each day to relax and gently unwind.

2. What you need to know before you take Mebeverine tablets

Do not take Mebeverine tablets

  • if you are allergic to mebeverine hydrochloride or any of the other ingredients of this medicine (listed in section 6).
  • you are younger than 18 years of age

If any of the above applies to you, do not take this medicine and talk to your doctor or pharmacist.

Warnings and precautions

See your doctor before using any IBS treatment if you:

  • have not suffered from IBS before
  • have developed new symptoms or your symptoms have become worse • have liver or kidney problems

    Talk to your doctor or pharmacist if any of the following applies to you: • you are 40 years of age or over and your symptoms have changed or it has been some time since you last had IBS

    • you have blood in your stools (faeces)
    • you are feeling sick (nauseous) or are sick (vomiting)
    • you are looking pale and feeling tired
    • you have constipation
    • you have a fever
    • you have recently travelled abroad
    • you are pregnant or planning to become pregnant
    • you are a woman and you have unusual bleeding or discharge from your vagina
    • you have difficulty or pain when passing water (urinating) Your doctor will tell you whether it is safe for you to start taking Mebeverine tablets.

Other medicines and Mebeverine tablets

No interactions with other medicines are known.

Mebeverine tablets with food, drink and alcohol

You can drink alcohol while you are taking Mebeverine tablets.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. There is only limited information about the safety of Mebeverine for pregnant women.

Your doctor may advise you to stop taking Mebeverine tablets before you become pregnant or as soon as you know you are pregnant. Mebeverine tablets should not be used during breast-feeding.

Driving and using machines

This medicine is not likely to affect you being able to drive or use any tools or machines.

Mebeverine tablets contain lactose

This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars contact your doctor before taking this medicinal product.

Mebeverine tablets contain sodium

This medicine contains less than 1mmol sodium(23mg) per tablet that is to say essentially 'sodium-free'.

3. How to take Mebeverine tablets

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

  • Try to take the tablets 20 minutes before a meal – some people find their symptoms to be strongest after they have eaten.
  • Swallow the tablets whole with water. Do not chew the tablets.

Use in adults and the elderly

The recommended dose is 1 tablet three times a day.

The number of tablets you take can be lowered if your symptoms improve. Do not take more than 3 tablets per day.

Use in children and adolescents

Do not give Mebeverine tablets to children or adolescents younger than 18 years.

How to stop taking Mebeverine tablets

You can lower the dose if your symptoms get better.

If you take more Mebeverine tablets than you should

If you or someone else takes too many Mebeverine tablets (an overdose), talk to a doctor or go to a hospital straight away. Take the medicine pack with you.

If you forget to take Mebeverine tablets

If you miss a tablet, wait until the next dose is due. Do not try to make up for the dose you have missed. Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

210 X 297 mm Front

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you get any of these serious side effects, stop taking the tablets. See a doctor at once:

  • Difficulty in breathing, swelling of face, neck, tongue or throat (severe allergic reactions).

Additional side effects

These other effects are less serious. If they bother you, talk to a pharmacist: • Skin rash, red itchy skin.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Mebeverine tablets

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Mebeverine tablets contain

  • The active substance is mebeverine hydrochloride.
  • The other ingredients are lactose monohydrate, microcrystalline cellulose, povidone K-30, sodium starch glycolate, purified talc, magnesium stearate, hypromellose, polyethylene glycol/macrogol and titanium dioxide

What Mebeverine tablets look like and contents of the pack

Mebeverine Hydrochloride 135 mg Film-coated Tablets are white to off white, approximately 11 mm, round, film coated biconvex tablets, plain on both sides.

Mebeverine Hydrochloride 135 mg Film-coated Tablets are available in PVC/PVDC-aluminium blister packs containing 15 or 100 tablets. Not all pack sizes may be marketed.

Marketing Authorisation Holder

Dawa Limited

5 Sandridge Close,

Harrow, Middlesex,

HA1 1XD, UK.

Manufacturer

Drugsrus Limited

5 Sandridge Close,

Harrow, Middlesex,

HA1 1XD, UK.

This leaflet was last revised in September 2026.

Blind or partially sighted?

Is this leaflet hard to see or read? Call 020 8423 2111 to obtain the leaflet in a format suitable for you.

0520/L-3

210 X 297 mm Back

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 30684/0520

Last revision stated in the text: September 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Mebeverine Hydrochloride 135 mg film-coated tablets

Prescription needed? Depends on the pack size: pharmacy medicine (P) – sold only in pharmacies, prescription-only medicine (POM)
Active substance Mebeverine
Strength 135 mg
Pharmaceutical form Oral tablet
White to off white, approximately 11 mm, round, film-coated biconvex tablets, plain on both sides.
How is it taken Oral
Excipients Lactose monohydrate, Microcrystalline cellulose,, Povidone K-30, Sodium starch glycolate, Purified talc, Magnesium stearate, Hypromellose, Polyethylene glycol/macrogol Titanium dioxide
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 30 months
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Synthetic anticholinergics, esters with tertiary amino group
  1. A Alimentary tract and metabolism drugs
    1. A03 Drugs for functional gastrointestinal disorders
      1. A03A Drugs for functional gastrointestinal disorders
        1. A03AA Synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders
          1. A03AA04 mebeverine
Marketing authorisation PL 30684/0520 (first authorised 14 September 2026)
Marketing authorisation holder Dawa Limited
Codes BNF 01020000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.